Brokerages Set Integral Ad Science Holding Corp. (NASDAQ:IAS) PT at $16.33

Integral Ad Science Holding Corp. (NASDAQ:IAS) has received an average rating of “Moderate Buy” from the thirteen research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $16.58.

Several brokerages have commented on IAS. Barclays raised their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Monday. Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a report on Monday. Morgan Stanley raised their target price on shares of Integral Ad Science from $12.00 to $13.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 23rd. Loop Capital initiated coverage on shares of Integral Ad Science in a research report on Tuesday, April 30th. They issued a “buy” rating and a $15.00 price target for the company. Finally, Craig Hallum reduced their price target on shares of Integral Ad Science from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Friday, May 10th.

Integral Ad Science Stock Performance

NASDAQ:IAS opened at $10.62 on Friday. Integral Ad Science has a twelve month low of $7.98 and a twelve month high of $17.53. The company has a current ratio of 4.32, a quick ratio of 4.32 and a debt-to-equity ratio of 0.13. The company has a 50-day moving average of $9.90 and a 200-day moving average of $10.90. The firm has a market cap of $1.70 billion, a price-to-earnings ratio of 1,062.00, a price-to-earnings-growth ratio of 1.47 and a beta of 1.54.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Thursday, August 1st. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. Integral Ad Science had a net margin of 0.57% and a return on equity of 0.32%. The company had revenue of $129.01 million during the quarter, compared to analysts’ expectations of $126.31 million. During the same period last year, the company posted $0.05 earnings per share. The business’s revenue for the quarter was up 13.5% on a year-over-year basis. Analysts forecast that Integral Ad Science will post 0.22 earnings per share for the current fiscal year.

Insider Activity at Integral Ad Science

In related news, CAO Alexis Gil II sold 2,792 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $9.09, for a total transaction of $25,379.28. Following the transaction, the chief accounting officer now owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, CAO Alexis Gil II sold 2,792 shares of the firm’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $9.09, for a total transaction of $25,379.28. Following the transaction, the chief accounting officer now owns 145,550 shares of the company’s stock, valued at $1,323,049.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Lisa Utzschneider sold 6,445 shares of Integral Ad Science stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $9.68, for a total transaction of $62,387.60. Following the completion of the transaction, the chief executive officer now directly owns 214,563 shares in the company, valued at approximately $2,076,969.84. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 23,785 shares of company stock valued at $240,225. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Integral Ad Science

A number of institutional investors have recently modified their holdings of the company. M&T Bank Corp raised its position in shares of Integral Ad Science by 5.6% in the fourth quarter. M&T Bank Corp now owns 14,430 shares of the company’s stock valued at $207,000 after purchasing an additional 770 shares during the period. Ameritas Investment Partners Inc. raised its position in shares of Integral Ad Science by 40.1% in the first quarter. Ameritas Investment Partners Inc. now owns 6,724 shares of the company’s stock valued at $67,000 after purchasing an additional 1,924 shares during the period. American Trust grew its stake in shares of Integral Ad Science by 18.0% in the first quarter. American Trust now owns 13,742 shares of the company’s stock worth $137,000 after acquiring an additional 2,096 shares during the last quarter. Truist Financial Corp grew its stake in shares of Integral Ad Science by 25.7% in the fourth quarter. Truist Financial Corp now owns 22,872 shares of the company’s stock worth $329,000 after acquiring an additional 4,676 shares during the last quarter. Finally, Richelieu Gestion SA grew its stake in shares of Integral Ad Science by 35.0% in the first quarter. Richelieu Gestion SA now owns 19,501 shares of the company’s stock worth $194,000 after acquiring an additional 5,055 shares during the last quarter. Institutional investors own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.